New Rhythm Management Chief Says It’s A New Day For Quality At Boston Sci

The new president of Boston Scientific's cardiac rhythm management division, Fred Colen, says the company's shift to a statistics-grounded quality control system allows the firm to prevent product component problems that might previously have been missed

More from Archive

More from Medtech Insight